But the business wasn’t making any profit. Yes there was a very small amount of revenue, but there are plenty of competitors for that business, so consumers will go to competitors and no one will want to buy a business for any decent amount when it’s not making money and there is very little differentiation to competitors.
A sale would have been great, but it would have taken more time and potentially not have been very beneficial, so I think the company wants to quickly shift focus and power ahead with the medcan business. That’s where this stock could be worth billions in the future, as there are no real competitors to the drugs they are making and massive markets. All it would take is for one of these drugs to be successful and commercialized for IHL to be worth serious money. Then imagine what happens if more than one drug is successful!
IHL Price at posting:
5.4¢ Sentiment: Buy Disclosure: Held
